Mineralys Therapeutics (MLYS) announced that it has commenced an underwritten public offering of $250M of shares of its common stock. Mineralys ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback